Given the high specificity of PLA2R antibodies in patients with MN and the fact that PLA2R antibodies have not been detected in other glomerular diseases or healthy people, deferral of a kidney biopsy has been suggested in patients with nephrotic syndrome and PLA2R antibodies. This evidence concerns the gene PLA2R1 and nephrotic syndrome.